Meier A, Weidmann P, Glück Z, Keusch G, Grimm M, Minder I, Reubi F C
Klin Wochenschr. 1980 Jul 1;58(13):681-7. doi: 10.1007/BF01478605.
The efficacy and side effects of two potent vasodilatators, namely diazoxide and minoxidil given orally, were compared in 11 patients who had hypertension refractory to conventional drug treatment. The latter included diuretics, betablockers and/or sympatholytics, and either dihydralazine or prazosin. In a crossover approach, dihydralazine and prazosin were withdrawn and replaced by diazoxide or minoxidil. In nine patients the diazoxide phase preceded the minoxidil treatment, while in two it followed minoxidil treatment. Before introduction of the more potent vasodilators blood pressure averaged 181/107 mm Hg in the supine and 161/103 mm Hg in the upright position. Both, oral diazoxide (median dose 400 mg/d( and minoxidil (medium dose 17.5 mg/d) produced similar decreases (p < 0.02) in mean arterial pressure (-15%) in the supine and (-11 vs. -12%) in the upright position. They caused a comparable tendency for sodium retention and weight gain which could be satisfactorily controlled with increased diuretic therapy, except in one patient. Hypertrichosis occurred with both drugs, but tended to be somewhat milder with diazoxide. Electrocardiograms remained generally unchanged. Plasma glucose levels were increased during diazoxide treatment in six patients necessitating interruption of this therapy in four patients. It is concluded that the antihypertensive potency and most side effect of orally administered diazoxide are comparable to those of minoxidil, except for diazoxide-related hyperglycemia which may limit the use of this substance.
对11例常规药物治疗无效的高血压患者,比较了两种强效血管扩张剂口服给药的疗效和副作用。常规药物包括利尿剂、β受体阻滞剂和/或交感神经阻滞剂,以及双肼屈嗪或哌唑嗪。采用交叉治疗方法,停用双肼屈嗪和哌唑嗪,换用二氮嗪或米诺地尔。9例患者先接受二氮嗪治疗,后接受米诺地尔治疗,2例患者先接受米诺地尔治疗,后接受二氮嗪治疗。在使用更强效的血管扩张剂之前,仰卧位血压平均为181/107 mmHg,立位血压平均为161/103 mmHg。口服二氮嗪(中位剂量400 mg/d)和米诺地尔(中位剂量17.5 mg/d)均使仰卧位平均动脉压下降相似幅度(p<0.02)(-15%),立位平均动脉压下降幅度分别为-11%和-12%。二者均引起相似的钠潴留倾向和体重增加,除1例患者外,增加利尿剂治疗后可得到满意控制。两种药物均出现多毛症,但二氮嗪引起的多毛症稍轻。心电图一般无变化。6例患者在二氮嗪治疗期间血糖水平升高,4例患者因此中断治疗。结论是,口服二氮嗪的降压效力和大多数副作用与米诺地尔相当,但二氮嗪相关的高血糖可能限制该药物的使用。